Cargando…
Mechanisms of SARS-CoV-2-induced lung vascular disease: potential role of complement
The outbreak of COVID-19 disease, caused by SARS-CoV-2 beta-coronovirus, urges a focused search for the underlying mechanisms and treatment options. The lung is the major target organ of COVID-19, wherein the primary cause of mortality is hypoxic respiratory failure, resulting from acute respiratory...
Autores principales: | Stenmark, Kurt R., Frid, Maria G., Gerasimovskaya, Evgenia, Zhang, Hui, McCarthy, Mary K., Thurman, Joshua M., Morrison, Thomas E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138299/ https://www.ncbi.nlm.nih.gov/pubmed/34046161 http://dx.doi.org/10.1177/20458940211015799 |
Ejemplares similares
-
Local Complement Contributes to Pathogenic Activation of Lung Endothelial Cells in SARS-CoV-2 Infection
por: Zhang, Hui, et al.
Publicado: (2023) -
Inflammation, immunity, and vascular remodeling in pulmonary hypertension; Evidence for complement involvement?
por: Frid, Maria G., et al.
Publicado: (2020) -
RhoGTPase in Vascular Disease
por: Strassheim, Derek, et al.
Publicado: (2019) -
A current view of G protein-coupled receptor - mediated signaling in pulmonary hypertension: finding opportunities for therapeutic intervention
por: Strassheim, Derek, et al.
Publicado: (2018) -
Role of Inflammatory Cell Subtypes in Heart Failure
por: Strassheim, Derek, et al.
Publicado: (2019)